Literature DB >> 27221479

Innate Immune Receptors.

Natalia Muñoz-Wolf1, Ed C Lavelle2.   

Abstract

For many years innate immunity was regarded as a relatively nonspecific set of mechanisms serving as a first line of defence to contain infections while the more refined adaptive immune response was developing. The discovery of pattern recognition receptors (PRRs) revolutionised the prevailing view of innate immunity, revealing its intimate connection with adaptive immunity and generation of effector and memory T- and B-cell responses. Among the PRRs, families of Toll-like receptors (TLRs), C-type lectin receptors (CLR), retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs) and nucleotide-binding domain, leucine-rich repeat-containing protein receptors (NLRs), along with a number of cytosolic DNA sensors and the family of absent in melanoma (AIM)-like receptors (ALRs), have been characterised. NLR sensors have been a particular focus of attention, and some NLRs have emerged as key orchestrators of the inflammatory response through the formation of large multiprotein complexes termed inflammasomes. However, several other functions not related to inflammasomes have also been described for NLRs. This chapter introduces the different families of PRRs, their signalling pathways, cross-regulation and their roles in immunosurveillance. The structure and function of NLRs is also discussed with particular focus on the non-inflammasome NLRs.

Entities:  

Keywords:  Innate receptors; MyD88; NOD-like receptors; Non-inflammasome NLRs; Pattern-recognition receptors; Toll-like receptors

Mesh:

Substances:

Year:  2016        PMID: 27221479     DOI: 10.1007/978-1-4939-3566-6_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7.

Authors:  Simon Wisnovsky; Leonhard Möckl; Stacy A Malaker; Kayvon Pedram; Gaelen T Hess; Nicholas M Riley; Melissa A Gray; Benjamin A H Smith; Michael C Bassik; W E Moerner; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-02       Impact factor: 11.205

Review 2.  Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection.

Authors:  Mariya Farooq; Abdul Waheed Khan; Bilal Ahmad; Moon Suk Kim; Sangdun Choi
Journal:  Front Pharmacol       Date:  2022-06-30       Impact factor: 5.988

Review 3.  NOD-like receptors: major players (and targets) in the interface between innate immunity and cancer.

Authors:  Fernando J Velloso; Marina Trombetta-Lima; Valesca Anschau; Mari C Sogayar; Ricardo G Correa
Journal:  Biosci Rep       Date:  2019-04-09       Impact factor: 3.840

Review 4.  Innate Immune Recognition: An Issue More Complex Than Expected.

Authors:  Klara Kubelkova; Ales Macela
Journal:  Front Cell Infect Microbiol       Date:  2019-07-03       Impact factor: 5.293

Review 5.  The innate immune perspective of autoimmune and autoinflammatory conditions.

Authors:  Shirly Frizinsky; Soad Haj-Yahia; Diti Machnes Maayan; Yulia Lifshitz; Ramit Maoz-Segal; Irean Offengenden; Mona Kidon; Nancy Agmon-Levin
Journal:  Rheumatology (Oxford)       Date:  2019-11-01       Impact factor: 7.580

6.  Editorial: Ligands, Adaptors and Pathways of TLRs in Non-mammals.

Authors:  Jianguo Su; Xiaoqiang Yu
Journal:  Front Immunol       Date:  2019-10-17       Impact factor: 7.561

7.  HB-EGF Plays a Pivotal Role in Mucosal Hyperplasia During Otitis Media Induced by a Viral Analog.

Authors:  Takashi Sakamoto; Kwang Pak; Eduardo Chavez; Allen F Ryan; Arwa Kurabi
Journal:  Front Cell Infect Microbiol       Date:  2022-02-23       Impact factor: 5.293

Review 8.  The Absent in Melanoma 2-Like Receptor IFN-Inducible Protein 16 as an Inflammasome Regulator in Systemic Lupus Erythematosus: The Dark Side of Sensing Microbes.

Authors:  Valeria Caneparo; Santo Landolfo; Marisa Gariglio; Marco De Andrea
Journal:  Front Immunol       Date:  2018-05-28       Impact factor: 7.561

Review 9.  Crosstalk between NLRP12 and JNK during Hepatocellular Carcinoma.

Authors:  Shahanshah Khan; Hasan Zaki
Journal:  Int J Mol Sci       Date:  2020-01-13       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.